⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of EIPICO and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
EIPICO
↗10th of Ramadan City, Egypt
EIPICO is the leading pharmaceutical company in Egypt and a major producer in the MENA region. Established in 1980, the company operates extensive manufacturing facilities in 10th of Ramadan City, producing over 400 pharmaceutical products across 25 therapeutic groups, including antibiotics, ophthalmics, and lyophilized products.
EIPICO is currently expanding its capabilities into biotechnology and biosimilars through its 'EIPICO 3' facility, the first of its kind in Egypt. The company maintains a strong export presence, reaching over 70 countries, and is listed on the Egyptian Exchange.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$200M-$500M
Founded:1980
Ownership:public
Status:operating
STOCK
Exchange:Egyptian Exchange (EGX)
Ticker:PHAR
PIPELINE
Stage:Phase 3
Lead Drug Stage:Commercial/Biosimilar development
Modalities:Small molecule, Biosimilars, Biologics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Egyptian International Company for Ampoules (EIACO), EIPICO Tech, Saudi Universal Factory
Key Partnerships:Pharmadule (Morimatsu Industry Group) for modular manufacturing, Reliance Life Sciences for biosimilar development
COMPETITION
Position:Leader
Competitors:EVA Pharma, Amoun Pharmaceutical Company, Pharco Pharmaceuticals, October Pharma
LEADERSHIP
Key Executives:
Khaled Salah Hagag - CEO
LINKS
Website:eipico.com.eg
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with EIPICO. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.